HomeRVLPQ • OTCMKTS
add
RVL Pharmaceuticals PLC
Previous close
$0.00050
Day range
$0.00 - $0.00
Market cap
110.00 USD
Avg Volume
16.69K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 8.26M | -2.25% |
Operating expense | 14.43M | -25.78% |
Net income | -23.89M | -97.33% |
Net profit margin | -289.28 | -101.87% |
Earnings per share | -0.08 | 50.94% |
EBITDA | -8.03M | 38.88% |
Effective tax rate | 0.47% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.16M | -30.11% |
Total assets | 85.40M | -31.58% |
Total liabilities | 69.08M | 4.16% |
Total equity | 16.33M | — |
Shares outstanding | 99.54M | — |
Price to book | 0.00 | — |
Return on assets | -20.66% | — |
Return on capital | -23.58% | — |
Cash Flow
Net change in cash
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -23.89M | -97.33% |
Cash from operations | -12.06M | -704.31% |
Cash from investing | -959.00K | -1,782.46% |
Cash from financing | -460.00K | 53.11% |
Net change in cash | -13.48M | -1,357.56% |
Free cash flow | -8.19M | -168.77% |
About
Website
Employees
125